Almost two-thirds of adults in Canada are overweight or living with obesity, according to the U.S. telehealth company ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to approve an oral version of its anti-obesity medication, moving ahead in ...

Telemedicine prescriptions of semaglutide and tirzepatide, combined with a virtual behavioral program, yielded weight loss ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

Long-term continuous treatment with anti-obesity medications may be necessary to sustain weight reduction and associated ...

The U.S. Anti-Obesity Drugs Market is projected to grow at a CAGR of 24.07%, supported by strong patient adoption of GLP-1 based therapies, expanding digital prescription platforms, and increasing ...

The American Medical Association (AMA) House of Delegates today passed the Endocrine Society's resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to ...

WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic. Hamlet Gasoyan, PhD, researcher at the ...

For 25 years, I’ve served as a rehabilitation counselor for the deaf at MassAbility, a state agency that helps individuals with disabilities find employment and live independently. I’m also the ...